Research outputs

  1. 2018
  2. Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival

    Hari, P., Reece, D. E., Randhawa, J., Flomenberg, N., Howard, D. S., Badros, A. Z., Rapoport, A. P., Meisenberg, B. R., Filicko-Ohara, J., Phillips, G. L. & Vesole, D. H., Jun 15 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-7 7 p.

    Research output: Contribution to journalArticle

  3. A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia

    Abou Dalle, I., Cortes, J. E., Pinnamaneni, P., Lamothe, B., Diaz Duque, A., Randhawa, J., Pemmaraju, N., Jabbour, E., Ferrajoli, A., Wierda, W. G., Estrov, Z., Konopleva, M., Ravandi, F., Alvarado, Y., Borthakur, G., Gandhi, V. & Kantarjian, H. M., 2018, (Accepted/In press) In : Acta Haematologica. p. 30-39 10 p.

    Research output: Contribution to journalArticle

  4. 2017
  5. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

    Daher, M., Hidalgo Lopez, J. E., Randhawa, J., Jabbar, K. J., Wei, Y., Pemmaraju, N., Borthakur, G., Kadia, T., Konopleva, M., Kantarjian, H. M., Hearn, K., Estrov, Z., Reyes, S., Bueso-Ramos, C. E. & Garcia-Manero, G., Jul 1 2017, In : American Journal of Hematology. 92, 7, p. 674-682 9 p.

    Research output: Contribution to journalArticle

  6. 2016
  7. A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia

    Randhawa, J. & Ferrajoli, A., Mar 3 2016, In : Expert Review of Hematology. 9, 3, p. 235-244 10 p.

    Research output: Contribution to journalArticle

  8. 2014
  9. Allogeneic hematopoietic cell transplantation in multiple myeloma

    Randhawa, J., Singh, V. & Hari, P., Jun 20 2014, Cancer Consult: Expertise for Clinical Practice. Wiley, p. 381-387 7 p.

    Research output: Chapter in Book/Report/Conference proceedingChapter

  10. Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent

    Randhawa, J., Wong, S., Atallah, E. & Olasz, E., Jan 2014, In : International Journal of Dermatology. 53, 1

    Research output: Contribution to journalLetter

  11. 2012
  12. Splenomegaly in myelofibrosis-new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors

    Randhawa, J., Ostojic, A., Vrhovac, R., Atallah, E. & Verstovsek, S., 2012, In : Journal of Hematology and Oncology. 5, 43.

    Research output: Contribution to journalReview article

ID: 39394245